Navigation Links
Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
Date:1/16/2012

SCOTTSDALE, Ariz., Jan. 16, 2012 /PRNewswire/ -- Regenesis Biomedical, Inc., a medical technology company that markets the Provant® Therapy System, announced today that Scott Brooks has joined the company in the newly created position of Chief Operating Officer. Scott is responsible for helping scale the organization's capabilities to support increased market penetration and broadened reimbursement.

(Logo: http://photos.prnewswire.com/prnh/20120109/LA31405LOGO)

Most recently Scott was President of sales, marketing and customer service at BSN Medical located in Charlotte, NC. He led a team of 190 people in the US and Canada. Prior to that, Scott was the VP of Sales and National Accounts at Kinetic Concepts Inc. (KCI), the marketer of the wound VAC. At KCI he managed a team of sales and national accounts professionals who sold advanced wound care, critical care, and bariatric care devices in the US to hospitals, nursing homes, and homecare. Scott served on the KCI management team as the company emerged into a global leader. His experience includes successful leadership positions with The Hill-Rom Company, Kimberly Clark Health Care, and Covidien.

"Scott is a mission focused, strategic, and process minded leader with experience scaling an organization," said Virginia Rybski, President and CEO of Regenesis. "We look forward to his contributions in building upon our performance based culture."

About Regenesis Biomedical

Regenesis Biomedical, Inc. is a privately held medical technology company focused on developing and marketing noninvasive regenerative medicine products. Regenesis developed, patented, and now markets the Provant Therapy System. Our customers include health care facilities, acute care hospitals, long-term acute care hospitals, skilled nursing facilities, rehabilitation centers, home health care agencies, and wound care clinics.

About the Provant® Therapy System

Provant uses pulsed radio frequency energy (PRFE) to facilitate reduction of the pain and edema associated with post-operative, superficial soft tissues.

Contact: Regenesis Biomedical, Inc.
Scott Robey, Vice President Marketing
www.regenesisbio.com
480-970-4970 phone


'/>"/>
SOURCE Regenesis Biomedical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Oncobiologics Appoints Scott Canute, Former President of Eli Lilly and Genzyme, to its Board of Directors
2. Pioneering US/Scottish Alliance for Life Science and Clinical Informatics
3. Scotland Announces Goal to Double Life Sciences Contribution to Scottish Economy by 2020 at BIO
4. Scott Garrett Joins Water Street Healthcare Partners
5. TGen and Scottsdale Healthcare researchers discover microRNA role in brain metastasis
6. Scott & White Healthcare President and CEO Alfred B. Knight, M.D. to Retire in 2011, Will Lead Foundation
7. Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing
8. Oncothyreon appoints Scott Peterson as Vice President of Research and Development
9. SIRO Group Appoints Scott L. Spector as President, Strategic Operations, for its European Business
10. United States Recognizes Leading Scottish Scientist for Disease Research
11. MedTrust Online and Scottsdale Clinical Research Institute at Scottsdale Healthcare Announce Collaboration to Provide Cutting Edge Technology to Improve Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2019)... PINE BROOK, N.J. (PRWEB) , ... May 03, ... ... visual electrophysiology, announces the release of the Diopsys® ffERG/Photopic Negative Response ... signs of glaucoma. , By 2050, it is estimated that 6.3 million Americans ...
(Date:5/2/2019)... ... April 30, 2019 , ... The centuries old practice ... macro breweries to local craft breweries, and even home brewing clubs scattered across the ... and biological processes, that when mastered can produce a superb product. Students at ...
(Date:5/2/2019)... ... May 02, 2019 , ... ... will present results documenting discrepancies between U.S. insurer policies for genetic testing and ... risk for hereditary breast and ovarian cancer (HBOC). , Jill S. ...
(Date:4/25/2019)... ... April 23, 2019 , ... Frank is an albino, deaf Great Dane. His owners ... him due to his health issues. Despite his hearing impairment, he was always an active ... two would play all day, every day. As the two grew, playtime became rougher and ...
Breaking Biology Technology:
(Date:6/4/2019)... ... June 04, 2019 , ... Most preclinical EEG visualization ... risk signals, usually based on variations of amplitude, frequency or spike train detection. ... methodology due to the complexity and variability of the signal, and automation tools ...
(Date:5/31/2019)... ... May 30, 2019 , ... Researchers ... Mayo Clinic, have documented significant differences in the prevalence of hereditary genetic mutations, ... compared to non-Hispanic White women. Results will be presented at the 2019 American ...
(Date:5/24/2019)... ... 24, 2019 , ... The newest edition of Crystallography Times from ... global website. , Crystallography Times is a monthly electronic newsletter published by Rigaku Oxford ... analysis community by presenting the latest news and crystallographic research. , “Crystallography in ...
Breaking Biology News(10 mins):